Nouvelles AMM: Pembrolizumab en deuxième ligne des tumeurs métastatiques MSI-H/dMMR Miscellaneous
| Authors: | El-Ghazzi, N.; Rousseau, B.; Rodrigues, M. |
| Title: | Nouvelles AMM: Pembrolizumab en deuxième ligne des tumeurs métastatiques MSI-H/dMMR |
| Keywords: | endometrial cancer; endometrium cancer; letter; colorectal cancer; cancer immunotherapy; monoclonal antibody; colorectal neoplasms; immunotherapy; colorectal tumor; mismatch repair; microsatellite instability; dna mismatch repair; stomach cancer; biliary cancer; intestine cancer; biliary tract cancer; biliary tract neoplasms; biliary tract tumor; gastric cancer; mismatch repair deficiency; antibodies, monoclonal, humanized; new drug; humans; human; pembrolizumab; new drug application |
| Journal Title: | Bulletin du Cancer |
| Volume: | 110 |
| Issue: | 1 |
| ISSN: | 0007-4551 |
| Publisher: | John Libbey Eurotext |
| Date Published: | 2023-01-01 |
| Start Page: | 11 |
| End Page: | 13 |
| Language: | French |
| DOI: | 10.1016/j.bulcan.2022.10.003 |
| PUBMED: | 36357200 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | "New drug approval: Pembrolizumab as second-line treatment in MSI-H/dMMR endometrial, colorectal, gastric, intestinal and biliary cancers” -- Source: Scopus |
